You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
Attention Score in Context
Title |
Intravenous beta<sub>2</sub>‐agonists versus intravenous aminophylline for acute asthma
|
---|---|
Published in |
Cochrane database of systematic reviews, December 2012
|
DOI | 10.1002/14651858.cd010256 |
Pubmed ID | |
Authors |
Andrew H Travers, Arthur P Jones, Carlos A Camargo, Stephen J Milan, Brian H Rowe |
Abstract |
Inhaled beta(2)-agonist therapy is central to the management of acute asthma. For rapid bronchodilation in severe cases, penetration of inhaled drug to the affected small conducting airway may be impeded, and the intravenous (IV) rather than inhaled administration of bronchodilators may provide an earlier response. IV beta(2)-agonist agents and IV aminophylline may also be considered as additional interventions in this setting and this review compares IV beta-agonist agents and IV aminophylline in the treatment of people with acute asthma. |
X Demographics
The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Australia | 6 | 55% |
Mexico | 1 | 9% |
Venezuela, Bolivarian Republic of | 1 | 9% |
Unknown | 3 | 27% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 8 | 73% |
Practitioners (doctors, other healthcare professionals) | 2 | 18% |
Science communicators (journalists, bloggers, editors) | 1 | 9% |
Mendeley readers
The data shown below were compiled from readership statistics for 202 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Colombia | 1 | <1% |
United States | 1 | <1% |
Peru | 1 | <1% |
Unknown | 199 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 32 | 16% |
Researcher | 17 | 8% |
Student > Bachelor | 17 | 8% |
Other | 13 | 6% |
Student > Ph. D. Student | 10 | 5% |
Other | 31 | 15% |
Unknown | 82 | 41% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 72 | 36% |
Nursing and Health Professions | 16 | 8% |
Psychology | 7 | 3% |
Social Sciences | 6 | 3% |
Economics, Econometrics and Finance | 3 | 1% |
Other | 12 | 6% |
Unknown | 86 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 May 2019.
All research outputs
#2,233,197
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#4,613
of 11,499 outputs
Outputs of similar age
#20,146
of 286,552 outputs
Outputs of similar age from Cochrane database of systematic reviews
#62
of 195 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 286,552 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 195 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.